Form 4: Hims & Hers Health Director David B. Wells Acquires Shares Through RSU Vesting

Director David B. Wells of Hims & Hers Health, Inc. acquired 10,046 shares of Class A Common Stock and vested in 10,046 Restricted Stock Units on December 13, 2024.

Summary

• David B. Wells, a director at Hims & Hers Health, Inc., acquired 10,046 shares of Class A Common Stock on December 13, 2024.
• This acquisition was a result of the vesting of 10,046 Restricted Stock Units (RSUs).
• The RSUs vest over a four-year period, with 25% vesting after one year and the remaining 75% vesting quarterly over the following three years.
• The vesting dates are March 15, June 15, September 15, and December 15 each year.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard transaction for a company that uses stock-based compensation for its directors. It is common for directors to receive stock options or restricted stock units that vest over time.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies, particularly in the tech and healthcare sectors, where Hims & Hers operates.
• Many companies use a similar four-year vesting schedule for restricted stock units, with a one-year cliff followed by quarterly vesting.
• Companies like Teladoc Health and GoodRx also use stock-based compensation as part of their overall compensation strategy.

Stakeholder Impact

• The vesting of RSUs and subsequent share acquisition may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Hims & Hers Health, Director, David B. Wells, Restricted Stock Units, RSU, Share Acquisition, Vesting, Class A Common Stock